Breaking News

Almac, UCL in Metagenomics Pact

Will combine chemistry and engineering with biocatalysis expertise

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The Almac biocatalysis group has secured a BBSRC (Biotechnology and Biological Sciences Research Council) program with UCL focused on metagenomics and enzyme discovery. Almac and the departments of Biochemical Engineering and Chemistry at UCL will perform the R&D work, with the input from Professors John Ward and Helen Hailes, leaders in the field of biocatalyst discovery and application.    A limitation of biocatalysis can be the number of diverse enzymes available in a given enzyme class. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters